Molecular similarity in medicinal chemistry

Journal of Medicinal Chemistry

Volumn 57, Issue 8, 2014, Pages 3186-3204

  Maggiora, Gerald ^a,b   Vogt, Martin ^c   Stumpfe, Dagmar ^c   Bajorath, Jürgen ^c  

^a UNIVERSITY OF ARIZONA   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR;

BIOLOGICAL FUNCTIONS; BIOLOGICAL SIMILARITY; CHEMICAL STRUCTURE; CHEMISTRY; COGNITION; HUMAN; MEDICINAL CHEMISTRY; MOLECULAR SIMILARITY; PERCEPTION; PHARMACOPHORE; PREDICTION; REVIEW; STRUCTURE ACTIVITY RELATION; SUPRAMOLECULAR CHEMISTRY; WORKING MEMORY;

CHEMISTRY, PHARMACEUTICAL; COMPUTATIONAL BIOLOGY; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 84894057083     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm401411z     Document Type: Review

References (63)

1. Bender, A.; Glen, R. B. Molecular Similarity: A Key Technique in Molecular Informatics Org. Biomol. Chem. 2004, 2, 3204-3218
2. Medina-Franco, J. L.; Maggiora, G. M. Molecular Similarity Analysis. In Chemoinformatics for Drug Discovery; Bajorath, J., Ed.; John Wiley and Sons: Hoboken, NJ, in press.
3. Kubinyi, H. Similarity and Dissimilarity: A Medicinal Chemist's View Perspect. Drug Discovery Des. 1998, 9-11, 225-232
4. Eckert, H.; Bajorath, J. Molecular Similarity Analysis in Virtual Screening: Foundations, Limitations and Novel Approaches Drug Discovery Today 2007, 12, 225-233
5. Koeppen, H. Virtual Screening-What Does It give Us? Curr. Opin. Drug Discovery Dev. 2009, 12, 397-407
6. Willett, P. Similarity-Based Virtual Screening Using 2D Fingerprints Drug Discovery Today 2006, 11, 1046-1053
7. Stumpfe, D.; Bajorath, J. Similarity Searching Wiley Interdiscip. Rev.: Comput. Mol. Sci. 2011, 1, 260-282
8. Johnson, M.; Maggiora, G. M., Eds. Concepts and Applications of Molecular Similarity; John Wiley & Sons: New York, 1990.
9. Maggiora, G. M. On Outliers and Activity Cliffs-Why QSAR Often Disappoints J. Chem. Inf. Model. 2006, 46, 1535-1535
10. Stumpfe, D.; Bajorath, J. Exploring Activity Cliffs in Medicinal Chemistry J. Med. Chem. 2012, 55, 2932-2942
11. Stumpfe, D.; Hu, Y.; Dimova, D.; Bajorath, J. Recent Progress in Understanding Activity Cliffs and their Utility in Medicinal Chemistry. J. Med. Chem. [Online early access]. DOI: 10.1021/jm401120g. Published Online: Aug 27, 2013.
12. Raymond, J. W.; Willett, P. Maximum Common Subgraph Isomorphism Algorithms for the Matching of Chemical Structures J. Comput.-Aided Mol. Des. 2002, 16, 521-533
13. MACCS Structural Keys; Accelrys: San Diego, CA.
14. Rogers, D.; Hahn, M. Extended-Connectivity Fingerprints J. Chem. Inf. Model. 2010, 50, 742-754
15. Good, A. C.; Richards, W. G. Explicit Calculation of 3D Molecular Similarity Perspect. Drug Discovery Des. 1998, 9-11, 321-338
16. Rush, T. S.; Grant, J. A.; Mosyak, L.; Nicholls, A. A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein-Protein Interaction J. Med. Chem. 2005, 48, 1489-1495
17. Brown, R. D.; Martin, Y. C. The Information Content of 2D and 3D Structural Descriptors Relevant to Ligand-Receptor Binding J. Chem. Inf. Model. 1997, 37, 1-9
18. McGaughey, G. B.; Sheridan, R. P.; Bayly, C. I.; Culberson, J. C.; Kreatsoulas, C.; Lindsley, S.; Maiorov, V.; Truchon, J.-F.; Cornell, W. D. Comparison of Topological, Shape, and Docking Methods in Virtual Screening J. Chem. Inf. Model. 2007, 47, 1504-1519
19. Fliri, A.; Loging, W.; Thadeio, P. F; Volkmann, R. Biological Spectra Analysis: Linking Biological Activity Profiles to Molecular Structure Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 261-266
20. Petrone, P. M.; Simms, B.; Nigsch, F.; Lounkine, E.; Kuthukian, P.; Cornett, A.; Deng, Z.; Davies, J. W.; Jenkins, J. L.; Glick, M. Rethinking Molecular Similarity: Comparing Compounds on the Basis of Biological Activity ACS Chem. Biol. 2012, 7, 1399-1409
21. Hu, Y.; Bajorath, J. Compound Promiscuity: What Can We Learn from Current Data? Drug Discovery Today 2013, 18, 644-650
22. Duda, R. O.; Hart, P. E.; Stork, D. G. Pattern Classification; Wiley: New York, 2001.
23. Bishop, C. M. Pattern Recognition and Machine Learning; Springer: Berlin, 2006.
24. Willett, P.; Barnard, J. M.; Downs, G. M. Chemical Similarity Searching J. Chem. Inf. Comput. Sci. 1998, 38, 983-996
25. Maggiora, G. M.; Shanmugasundaram, V. Molecular Similarity Measures Methods Mol. Biol. 2004, 275, 1-50
26. Takaoka, Y.; Endo, Y.; Yamanobe, S.; Kakinuma, H.; Okubo, T.; Shimazaki, Y.; Ota, T.; Sumiya, S.; Yoshikawa, K. Development of a Method for Evaluating Drug-likeness and Ease of Synthesis Using a Dataset in Which Compounds Are Assigned Scores Based on Chemists' Intuition J. Chem. Inf. Comput. Sci. 2003, 43, 1269-1275
27. Lajiness, M. S.; Maggiora, G. M.; Shanmugasundaram, V. Assessment of the Consistency of Medicinal Chemists in Reviewing Sets of Compounds J. Med. Chem. 2004, 47, 4891-4896
28. Kutchukian, P. S.; Vasilyeva, N. Y.; Xu, J.; Lindvall, M. K.; Dillon, M. P.; Glick, M.; Cooley, J. D.; Brooijmans, N. Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery PLoS One 2012, 7, e48476
29. Gasteiger, J.; Teckentrup, A.; Terfloth, L.; Spycher, S. Neural Networks as Data Mining Tools in Drug Design J. Phys. Org. Chem. 2003, 16, 232-245
30. Burges, C. J. C. A Tutorial on Support Vector Machines for Pattern Recognition Data Min. Knowl. Discovery 1998, 2, 121-167
31. Rusinko, A., III; Farmen, M. W.; Lambert, C. G.; Brown, P. L.; Young, S. S. Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning J. Chem. Inf. Comput. Sci. 1999, 39, 1017-1026
32. Auer, J.; Bajorath, J. Emerging Chemical Patterns: A New Methodology for Molecular Classification and Compound Selection J. Chem. Inf. Model. 2006, 46, 2502-2514
33. Tanimoto, T. T. IBM Internal Report; IBM Corporation: Armonk, NY, Nov 17, 1957.
34. Tversky, A. Features of Similarity Psychol. Rev. 1977, 84, 327-352
35. Flower, D. R. On the Properties of Bit String-Based Measures of Chemical Similarity J. Chem. Comput. Sci. 1998, 38, 379-386
36. Wang, Y.; Eckert, H.; Bajorath, J. Apparent Asymmetry in Fingerprint Similarity Searching Is a Direct Consequence of Differences in Bit Densities and Molecular Size ChemMedChem 2007, 2, 1037-1042
37. Fligner, M.; Verducci, J.; Blower, P. A Modification of the Jaccard-Tanimoto Similarity Index for Diverse Selection of Chemical Compounds Using Binary Strings Technometrics 2002, 44, 110-119
38. Wang, Y.; Bajorath, J. Advanced Fingerprint Methods for Similarity Searching: Balancing Molecular Size Effects Comb. Chem. High Throughput Screening 2010, 13, 220-228
39. Nisius, B.; Bajorath, J. Rendering Conventional Molecular Fingerprints for Virtual Screening Independent of Molecular Complexity and Size Effects ChemMedChem 2010, 5, 859-868
40. Becker, J. T.; Morris, R. G. Working Memory(s) Brain Cognit. 1999, 41, 1-8
41. Cowan, N. What Are the Differences between Long-Term, Short-Term, and Working Memory? Prog. Brain Res. 2008, 169, 323-338
42. Hodgetts, C. J.; Hahn, U. Similarity-Based Asymmetries in Perceptual Matching Acta Psychol. 2012, 139, 291-299
43. Patterson, D. E.; Cramer, R. D.; Ferguson, A. M.; Clark, R. D.; Weinberger, L. E. Neighborhood Behavior-A Useful Concept for Validation of Molecular Diversity Descriptors J. Med. Chem. 1996, 39, 3049-3059
44. Martin, Y. C.; Kofron, J. L.; Traphagen, L. M. Do Structurally Similar Compounds Have Similar Biological Activity? J. Med. Chem. 2002, 45, 4350-4358
45. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A Free Tool To Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757-1768
46. Molecular Operating Environment (MOE); Chemical Computing Group Inc.: Montreal, Quebec, Canada.
47. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery Nucleic Acids Res. 2011, 40, D1100-D1107
48. Bender, A. How Similar Are Those Molecules After All? Use Two Descriptors and You Will Have Three Different Answers Expert Opin. Drug Discovery 2010, 5, 1141-1151
49. Sheridan, R. P. Similarity Searching: When Is Complexity Justified? Expert Opin. Drug Discovery 2007, 2, 423-430
50. Willett, P. Combinations of Similarity Rankings Using Data Fusion J. Chem. Inf. Model. 2013, 53, 1-10
51. Mason, J. S.; Good, A. C.; Martin, E. J. 3-D Pharmacophores in Drug Discovery Curr. Pharm. Des. 2001, 7, 567-597
52. Renner, S.; Schneider, G. Scaffold-Hopping Potential of Ligand-Based Similarity Concepts ChemMedChem 2006, 1, 181-185
53. Vogt, M.; Stumpfe, D.; Geppert, H.; Bajorath, J. Scaffold Hopping Using Two-Dimensional Fingerprints: True Potential, Black Magic, or a Hopeless Endeavor? Guidelines for Virtual Screening J. Med. Chem. 2010, 53, 5707-5715
54. Stumpfe, D.; Bill, A.; Novak, N.; Loch, G.; Blockus, H.; Geppert, H.; Becker, T.; Hoch, M.; Schmitz, A.; Kolanus, W.; Famulok, M.; Bajorath, J. Targeting Multi-Functional Proteins by Virtual Screening: Structurally Diverse Cytohesin Inhibitors with Differentiated Biological Functions ACS Chem. Biol. 2010, 5, 839-849
55. Kolanus, W. Guanine Nucleotide Exchange Factors of the Cytohesin Family and Their Roles in Signal Transduction Immunol. Rev. 2007, 218, 102-113
56. Dimova, D.; Stumpfe, D.; Bajorath, J. Quantifying the Fingerprint Descriptor Dependence of Structure-Activity Relationship Information on a Large Scale J. Chem. Inf. Model. 2013, 53, 2275-2281
57. Lajiness, M. S. Dissimilarity-Based Compound Selection Techniques Perspect. Drug Discovery Des. 1997, 7-8, 65-84
58. Gillet, V. J. Diversity Selection Algorithms. Wiley Interdiscip. Rev.: Comput. Mol. Sci. 2011, 1, 580-589.
59. Rouvray, D. H. The Evolution of the Concept of Molecular Similarity. In Concepts and Applications of Molecular Similarity; Johnson, M., Maggiora, G. M., Eds.; John Wiley & Sons: New York, 1990; pp 15-42.
60. Hu, Y.; Bajorath, J. Global Assessment of Scaffold Hopping Potential for Current Pharmaceutical Targets. Med. Chem. Commun. 2010, 1, 339-344.
61. Moffat, K.; Gillet, V. J.; Whittle, M.; Bravi, G.; Leach, A. R. A Comparison of Field-Based Similarity Searching Methods: CatShape, FBSS, and ROCS. J. Chem. Inf. Model. 2008, 48, 719-729.
62. Tresadern, G.; Bemporad, D. Modeling Approaches for Ligand-Based 3D Similarity. Future Med. Chem. 2010, 2, 1547-1561.
63. Wassermann, A. M.; Wawer, M.; Bajorath, J. Activity Landscape Representations for Structure-Activity Relationship Analysis. J. Med. Chem. 2010, 53, 8209-8223.